Literature DB >> 23219199

Immunosignaturing: a critical review.

Kathryn F Sykes1, Joseph B Legutki, Phillip Stafford.   

Abstract

Health is a complex interaction between metabolism, physiology, and immunity. Although it is difficult to define quantitatively, the activity of the humoral immune system provides a reasonable proxy for changes in health. Immunosignaturing is a microarray-based technology that quantitates the dynamics of circulating antibodies. Recent advancements in the field warrant a review of the technology. Here, we provide an introduction to the technique, evaluate the current progress, contrast similar technologies, and suggest applications that immunosignaturing could facilitate.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 23219199     DOI: 10.1016/j.tibtech.2012.10.012

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  19 in total

1.  High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor Microarrays.

Authors:  Jung-Rok Lee; D James Haddon; Nidhi Gupta; Jordan V Price; Grace M Credo; Vivian K Diep; Kyunglok Kim; Drew A Hall; Emily C Baechler; Michelle Petri; Madoo Varma; Paul J Utz; Shan X Wang
Journal:  ACS Nano       Date:  2016-09-20       Impact factor: 15.881

2.  Epitope identification from fixed-complexity random-sequence peptide microarrays.

Authors:  Josh Richer; Stephen Albert Johnston; Phillip Stafford
Journal:  Mol Cell Proteomics       Date:  2014-11-03       Impact factor: 5.911

3.  Antibody repertoire profiling with mimotope arrays.

Authors:  Shina Pashova; Christoph Schneider; Stephan von Gunten; Anastas Pashov
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

4.  Immunosignature system for diagnosis of cancer.

Authors:  Phillip Stafford; Zbigniew Cichacz; Neal W Woodbury; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

5.  Application of immunosignatures for diagnosis of valley fever.

Authors:  Krupa Arun Navalkar; Stephen Albert Johnston; Neal Woodbury; John N Galgiani; D Mitchell Magee; Zbigniew Chicacz; Phillip Stafford
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

6.  Immunosignatures can predict vaccine efficacy.

Authors:  Joseph Barten Legutki; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

7.  Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.

Authors:  Anton N Chikaev; Anastasiya Yu Bakulina; Ryan C Burdick; Larisa I Karpenko; Vinay K Pathak; Alexander A Ilyichev
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  A General Method to Discover Epitopes from Sera.

Authors:  Kurt Whittemore; Stephen Albert Johnston; Kathryn Sykes; Luhui Shen
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

9.  Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.

Authors:  Panagiotis Karagiannis; Federica Villanova; Debra H Josephs; Isabel Correa; Mieke Van Hemelrijck; Carl Hobbs; Louise Saul; Isioma U Egbuniwe; Isabella Tosi; Kristina M Ilieva; Emma Kent; Eduardo Calonje; Mark Harries; Ian Fentiman; Joyce Taylor-Papadimitriou; Joy Burchell; James F Spicer; Katie E Lacy; Frank O Nestle; Sophia N Karagiannis
Journal:  Oncoimmunology       Date:  2015-06-03       Impact factor: 8.110

10.  The immunosignature of canine lymphoma: characterization and diagnostic application.

Authors:  Stephen Albert Johnston; Douglas H Thamm; Joseph Barten Legutki
Journal:  BMC Cancer       Date:  2014-09-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.